Privi Speciality to hold shareholder meet Oct 27 for subsidiary mergers
- Equity shareholders' meeting scheduled for October 27, 2026, via VC/OAVM
- Agenda includes approval of amalgamation with Privi Fine Sciences and Privi Biotechnologies
- NCLT Mumbai Bench directed the meeting via order dated September 7, 2026
- Remote e-voting opens October 22, 2026, and closes October 26, 2026

*this image is generated using AI for illustrative purposes only.
Privi Speciality Chemicals Limited has announced that a meeting of its equity shareholders will be held on Tuesday, October 27, 2026, at 12:30 pm via Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The primary agenda is to consider and approve the proposed Scheme of Amalgamation involving two private subsidiaries.
The National Company Law Tribunal (NCLT), Mumbai Bench, directed the convening of this meeting through an order dated September 7, 2026. The scheme involves the amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with the listed entity. These entities are referred to as Transferor Company 1 and Transferor Company 2, respectively, while the main company acts as the Transferee Company.
Meeting Logistics and Voting Details
The company dispatched the Notice of Meeting along with Annexures on September 24, 2026, to members whose email addresses were registered as of September 18, 2026. The notice and explanatory statement are also available on the company's official website. To facilitate participation, remote e-voting facilities will be provided alongside the virtual meeting.
| Particulars | Details |
|---|---|
| Meeting Date | October 27, 2026 |
| Time | 12:30 pm |
| Mode | VC / OAVM |
| Remote E-voting Start | October 22, 2026 at 9:00 am |
| Remote E-voting End | October 26, 2026 at 5:00 pm |
| Cut-off Date | October 20, 2026 |
Regulatory Framework
The proposed scheme is being executed under sections 230 to 232 and other applicable provisions of the Companies Act, 2013, along with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016. The NCLT order was passed in the Company Scheme Application No. CA(CAA)136/MB/2026.
Members can access the live webcast and voting portal through the designated link provided by the Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The company has ensured that all procedural requirements for the electronic dispatch of notices are met to enable seamless participation for equity shareholders.
Historical Stock Returns for Privi Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.55% | +1.64% | +1.67% | +24.11% | +44.74% | +91.75% |
How will the consolidation of Privi Fine Sciences and Privi Biotechnologies impact the company's consolidated revenue and EBITDA margins in the upcoming fiscal quarters?
What are the expected synergies in supply chain efficiency and R&D capabilities resulting from integrating these two private subsidiaries into the listed entity?
How might the simplification of the corporate structure through this amalgamation influence institutional investor sentiment and the stock's valuation multiples?
































